Magro F, Lopes SI, Lopes J, Portela F, Cotter J, Lopes S, Moreira MJ, Lago P, Peixe P, Albuquerque A, Rodrigues S, Silva MR, Monteiro P, Lopes C, Monteiro L, Macedo G, Veloso L, Camila C, Afonso J, Geboes K, Carneiro F, Portuguese IBD group [GEDII] F

Histological Outcomes and Predictive Value of Faecal Markers in Moderately to Severely Active Ulcerative Colitis Patients Receiving Infliximab. Journal of Crohn's & colitis 10: 1407-1416, 2016.  [Article] 

 doi: 10.1093/ecco-jcc/jjw112 PMID: 27226417.